[Progress in researches of in-vivo re-endothelialization at the site of implanting cardiovascular devices].

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi

College of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China.

Published: December 2009


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Restenosis and thrombus at the site of implanting cardiovascular devices remains a significant problem in the practice of interventional cardiology. Recently, lots of studies reveal that endothelial impairment was considered as one of the most important mechanisms contributing to restenosis. The method of accelerating endothelial regeneration at the injury site could prevent restenosis and thrombus, so such methods are of importance for improving the effectiveness of interventional therapy for atherosclerosis. This paper summarized the progress in researches in-vivo re-endothelialization at the site of intravascular stent.

Download full-text PDF

Source

Publication Analysis

Top Keywords

researches in-vivo
8
in-vivo re-endothelialization
8
re-endothelialization site
8
site implanting
8
implanting cardiovascular
8
restenosis thrombus
8
[progress researches
4
site
4
cardiovascular devices]
4
devices] restenosis
4

Similar Publications

Background: Activin A/Smad signaling plays an important role in promoting cancer stemness and chemoresistance in pancreatic ductal adenocarcinoma (PDAC), however the precise regulation on the termination of this pathway has not been fully understood.

Methods: LncRNA SLC7A11-AS1 interacting proteins were identified through RNA pull-down followed by LC-MS/MS. The protein interaction was analyzed by co-immunoprecipitation.

View Article and Find Full Text PDF

Pseudomonas aeruginosa (PA) represents a major cause of antimicrobial resistance-related morbidity and mortality. The recent emergence of highly fatal infections, caused by carbapenem-resistant PA, has called for novel antimicrobial therapies and strategies. In this study, we highlight the therapeutic potential of ε-poly-L-lysine (εPL), an antimicrobial polymer for treating extensively-and pan-drug-resistant-PA.

View Article and Find Full Text PDF

Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer.

Nat Cell Biol

September 2025

Department of Medicine, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Durotaxis, cell migration along stiffness gradients, is linked to embryonic development, tissue repair and disease. Despite solid in vitro evidence, its role in vivo remains largely speculative. Here we demonstrate that durotaxis actively drives disease progression in vivo in mouse models of lung fibrosis and metastatic pancreatic cancer.

View Article and Find Full Text PDF

Autism is a neurodevelopmental condition associated with altered resting-state brain function. An increased excitation-inhibition ratio is discussed as a pathomechanism but in-vivo evidence of disturbed neurotransmission underlying functional alterations remains scarce. We compare local resting-state brain activity and neurotransmitter co-localizations between autism (N = 405, N = 395) and neurotypical controls (N = 473, N = 474) in two independent cohorts and correlate them with excitation-inhibition changes induced by glutamatergic (ketamine) and GABAergic (midazolam) medication.

View Article and Find Full Text PDF

In recent years, there has been a rapid increase in the incidence of thyroid carcinoma (TC). Our study focuses on the regulatory effect of circular RNAs on metabolism of TC, aiming to provide new insights into the mechanisms of progression and a potential therapeutic target for TC. In this study, we identified high expression levels of circPSD3 in TC tissues through RNA sequencing.

View Article and Find Full Text PDF